Verrica Pharmaceuticals Inc (VRCA)
8.51
+0.18
(+2.16%)
USD |
NASDAQ |
May 31, 16:00
8.515
0.00 (0.00%)
After-Hours: 20:00
Verrica Pharmaceuticals Debt to Equity Ratio: 28.41 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 28.41 |
| December 31, 2023 | 2.169 |
| September 30, 2023 | 1.002 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2022 | 2.589 |
| March 31, 2022 | 1.652 |
| December 31, 2021 | 1.279 |
| September 30, 2021 | 1.012 |
| June 30, 2021 | 0.7862 |
| March 31, 2021 | 0.658 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2022
28.41
Maximum
Mar 2024
3.043
Average
1.002
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions Inc | 1.364 |
| Macrogenics Inc | 0.00 |
| Aquestive Therapeutics Inc | -0.7929 |
| Recursion Pharmaceuticals Inc | 0.0028 |
| Omega Therapeutics Inc | 0.4328 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 66.31M |
| Total Liabilities (Quarterly) | 64.80M |
| Shareholders Equity (Quarterly) | 1.508M |
| Current Ratio | 3.169 |
| Net Debt Paydown Yield | -3.41% |